Description
Bendamustine: a therapy from the past, for the present and future, in daily clinical practice
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: Bendamustine: a therapy from the past, for the present and future, in daily clinical practice
€3.03
Related products
-
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€209.83 Add to cart -
Article: Calendar of events
€3.03 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart -
1 year access Online Belgian Journal of Hematology (BJH)
€71.94 Add to cart
